Lakefront Biotherapeutics | GLPG - Capital Social e Reservas





Capital Social e Reservas Alterar Data
argenx SE USD 7.32B 1.23B 2025-12
AstraZeneca USD 47.33B 1.33B 2026-03
Biogen USD 18.65B 394.9M 2026-03
Genmab DKK 5.85B 96M 2025-12
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Merck EUR 29.74B 1.15B 2026-03
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03